[1]金荣杰 徐勇 邓珏琳 沈明志.应用心脏磁共振评估前列地尔对ST段抬高型心肌梗死患者心肌灌注的影响[J].心血管病学进展,2020,(10):1096.[doi:10.16806/j.cnki.issn.1004-3934.2020.10.023]
 JIN RongjieXU YongDENG JuelinSHEN Mingzhi.Effect of Alprostadil on Myocardial Perfusion of Patients with ST Segment Elevation Myocardial Infarction Directly Receiving Percutaneous Coronary Intervention Assessed with Cardiac Magnetic Resonance[J].Advances in Cardiovascular Diseases,2020,(10):1096.[doi:10.16806/j.cnki.issn.1004-3934.2020.10.023]
点击复制

应用心脏磁共振评估前列地尔对ST段抬高型心肌梗死患者心肌灌注的影响()
分享到:

《心血管病学进展》[ISSN:51-1187/R/CN:1004-3934]

卷:
期数:
2020年10期
页码:
1096
栏目:
论著
出版日期:
2020-10-25

文章信息/Info

Title:
Effect of Alprostadil on Myocardial Perfusion of Patients with ST Segment Elevation Myocardial Infarction Directly Receiving Percutaneous Coronary Intervention Assessed with Cardiac Magnetic Resonance
作者:
金荣杰2 徐勇2 邓珏琳1 沈明志1
1.中国人民解放军总医院海南医院心内科,海南 三亚 572013;2.中国人民解放军总医院第一医学中心心内科,北京 100853)
Author(s):
JIN Rongjie12XU Yong2DENG Juelin1SHEN Mingzhi1
(1.Department of Cardiology, Hainan Hospital of Chinese PLA General Hospital, Sanya 572013, Hainan, China2.Department of Cardiology, The First Medical Center of Chinese PLA General Hospital, Beijing 100853, China)
关键词:
前列地尔ST段抬高型心肌梗死挽救心肌心脏磁共振
Keywords:
AlprostadilST segment elevation myocardial infarctionSalvage myocardiumCardiac magnetic resonance
DOI:
10.16806/j.cnki.issn.1004-3934.2020.10.023
摘要:
目的 本研究旨在通过心脏磁共振评估前列地尔对ST段抬高型心肌梗死(STEMI)患者直接经皮冠脉介入术(PCI)心肌灌注的影响。方法 收集160例行直接PCI的STEMI患者,一组患者接受了STEMI常规治疗,一组患者加用了前列地尔。结果 两组患者的年龄、性别、病史和常规用药均无显著差异(均P>0.05)。通过心脏磁共振发现,前列地尔组患者的挽救心肌显著多于常规治疗组(P<0.05)。结论 STEMI直接PCI患者使用前列地尔后,心肌灌注显著改善,挽救心肌显著增加。
Abstract:
Objective To assess the effect of alprostadil on myocardial perfusion of patients with ST segment elevation myocardial infarction (STEMI) directly receiving percutaneous coronary intervention (PCI) with cardiac magnetic resonance (CMR). Methods There were 160 patients with STEMI directly receiving PCI, one group with conventional treatment for STEMI, and the other group with additional alprostadil. Results Patients in two groups had no significant difference in age, sex, medical histories and conventional drugs (all P<0.05). Assessed by CMR, salvage myocardium of patients in alprostadil group was significantly more than that in conventional group(P<0.05). Conclusion Alprostadil improved myocardial perfusion and increased salvage myocardium of patients with STEMI directly receiving PCI.

参考文献/References:

[1].Nabel EG,Braunwald E.A tale of coronary artery disease and myocardial infarction[J].N Engl J Med,2012,366(1):54-63.
[2].胡盛寿,高润霖,刘力生,等.《中国心血管病报告2018》概要[J].中国循环杂志,2019,34(3):209-220.
[3].王学工,肖明辉,唐晓波,等.前列地尔的剂型及研究新进展[J].黑龙江医药,2008,(6):37-40.
[4].Jogiya R,Kozerke S,Morton G,et al.Validation of dynamic 3-dimensional whole heart magnetic resonance myocardial perfusion imaging against fractional flow reserve for the detection of significant coronary artery disease[J].J Am Coll Cardiol,2012,60(8):756-765.
[5].Chen Y,Wang C,Yang X,et al.Independent no-reflow predictors in female patients with ST-elevation acute myocardial infarction treated with primary percutaneous coronary intervention[J].Heart Vessels,2012,27(3):243-249.
[6].Engblom H,Heiberg E,Erlinge D,et al.Sample size in clinical cardioprotection trials using myocardial salvage index,infarct Size,or biochemical markers as endpoint[J].J Am Heart Assoc,2016,5(3):e002708.
[7].Bulluck H,Rosmini S,Abdel-Gadir A,et al.Residual myocardial iron following intramyocardial hemorrhage during the convalescent phase of reperfused ST-segment-elevation myocardial infarction and adverse left ventricular remodeling[J].Circ Cardiovasc Imaging,2016,9(10):e004940.
[8].Messroghli DR,Moon JC,Ferreira VM,et al.Clinical recommendations for cardiovascular magnetic resonance mapping of T1,T2,T2* and extracellular volume:a consensus statement by the Society for Cardiovascular Magnetic Resonance (SCMR) endorsed by the European Association for Cardiovascular Imaging (EACVI)[J].J Cardiovasc Magn Reson,2017,19(1):75.
[9].Berry C,Kellman P,Mancini C,et al.Magnetic resonance imaging delineates the ischemic area at risk and myocardial salvage in patients with acute myocardial infarction[J].Circ Cardiovasc Imaging,2010,3(5):527-535.
[10].Hammer-Hansen S,Leung SW,Hsu LY,et al.Early gadolinium enhancement for determination of area at risk:a preclinical validation study[J].JACC Cardiovasc Imaging,2017,10(2):130-139.
[11].Garg P,Broadbent DA,Swoboda PP,et al.Acute infarct extracellular volume mapping to quantify myocardial area at risk and chronic infarct size on cardiovascular magnetic resonance imaging[J].Circ Cardiovasc Imaging,2017,10(7):e006182.
[12].汤晟凌,梁晓美,张国勇.前列地尔注射液的药理作用与临床应用进展[J].中国药房,2012,(25):2383-2385.
[13].Wei LY,Fu XH,Li W,et al.Effect of intravenous administration of liposomal prostaglandin E1 on microcirculation in patients with ST elevation myocardial infarction undergoing primary percutaneous intervention[J].Chin Med J (Engl),2015,128(9):1147-1150.
[14].Li JH,Yang P,Li AL,et al.Cardioprotective effect of liposomal prostaglandin E1 on a porcine model of myocardial infarction reperfusion no-reflow[J].J Zhe jiang Univ Sci B,2011,12(8):638-643.
[15].李勇,唐捷.前列地尔的药理研究进展[J].西南军医,2006,(6):79-81.

相似文献/References:

[1]刘丹丹 王海珠 任凤波.ST段抬高型心肌梗死PCI术后血浆微囊泡浓度对再次血运重建的风险预测分析[J].心血管病学进展,2019,(7):1056.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.023]
 LIU Dandan,WANG Haizhu,REN Fengbo.Predictive analysis of plasma microvesicles concentration in patients with ST-segment elevation myocardial infarction after target lesion revascularization[J].Advances in Cardiovascular Diseases,2019,(10):1056.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.023]
[2]韩培天 魏晓岩 杜彬彬 张津宁 王文州 郭艳娇 张克成 李春彦 李文慧.心肌缺血时间对STEMI患者急诊PCI术后早期左室舒张功能的影响及相关因素分析[J].心血管病学进展,2020,(6):660.[doi:10.16806/j.cnki.issn.1004-3934.2020.06.024]
 HAN Pei-tian,WEI Xiaoyan,DU Binbin,et al.Effect of Myocardial Ischemia Duration on Early Left Ventricular Diastolic Function in STEMI Patients After Emergency PCI and Analysis of Related Factors[J].Advances in Cardiovascular Diseases,2020,(10):660.[doi:10.16806/j.cnki.issn.1004-3934.2020.06.024]
[3]周星儿 赵施皓 郭宇婷 金荣杰 王继航 王建 郭毅 田进文 沈明志.冠状动脉溶栓在ST段抬高型心肌梗死中的研究进展[J].心血管病学进展,2022,(3):229.[doi:10.16806/j.cnki.issn.1004-3934.2022.03.000]
 ZHOU Xinger,ZHAO Shihao,GUO Yuting,et al.Coronary Thrombolysis in ST-Segment Elevation Myocardial Infarction[J].Advances in Cardiovascular Diseases,2022,(10):229.[doi:10.16806/j.cnki.issn.1004-3934.2022.03.000]
[4]宋艳华 来春林 杨五小.急性 ST段抬高型心肌梗死患者微血管功能障碍的研究进展[J].心血管病学进展,2022,(6):530.[doi:10.16806/j.cnki.issn.1004-3934.2022.06.013]
 SONG Yanhua,LAI Chunlin,YANG Wuxiao.Microvascular Dysfunction in Patients with Acute ST-Segment?levation Myocardial Infarction[J].Advances in Cardiovascular Diseases,2022,(10):530.[doi:10.16806/j.cnki.issn.1004-3934.2022.06.013]

备注/Memo

备注/Memo:
更新日期/Last Update: 2020-12-21